Impact
D-ID
Recorded November 25, 2024
D-ID’s AI-powered digital video platform seamlessly transforms images, text, videos, audio, and voice into highly engaging Digital People
D-ID’s AI-powered digital video platform seamlessly transforms images, text, videos, audio, and voice into highly engaging Digital People
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
Element Fleet has a developed a new securitized trust that has the potential to deliver significant tax advantages
The company’s AI-powered drug development program has the potential to treat multiple CNS diseases and impact millions of lives.
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
The company’s AI-powered drug development program has the potential to treat multiple CNS diseases and impact millions of lives.
A groundbreaking project that merges luxury car condominiums, high-end individual car storage, and a sophisticated lifestyle experience.
First-in-industry devices to optimize cancer therapies and address infectious disease disorders that are not treatable with drugs
CH4 Global has created a natural supplement that when added to a livestock feed prevents methane from being produced during digestion.
Using precision medicine to diagnose and treat psychiatric, cardiovascular, and neurologic disorders caused by immune disfunction
How EpiQuest [NASDAQ: EEIQ], is profitingby making a western higher education accessibleto the students around the world
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ to make cancer less lethal.